Soluble fibrin complexes in experimental thrombotic states
Chang, M.L.; Wilson, J.E.; Frenkel, E.P.
Journal of Laboratory and Clinical Medicine 84(2): 168-178
1974
ISSN/ISBN: 0022-2143 PMID: 4843224 Document Number: 76703
Document emailed within 1 workday
Related Documents
Benabid, Y.; Concord, E.; Suscillon, M. 1977: Soluble fibrin complexes: separation as a function of pH and characterization Thrombosis and Haemostasis 37(1): 144-153Kleniewski, J. 1971: Contents of soluble fibrin monomer complexes and fibrinogen in the plasma and erythrocyte sedimentation rate Polski Tygodnik Lekarski 26(17): 627-629
Dempfle, C.E.; Zips, S.; Ergül, H.; Heene, D.L. 2001: The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer Thrombosis and Haemostasis 86(5): 1204-1209
Kawai, Y. 2004: Soluble fibrin monomer complex (SFMC), soluble fibrin monomer (SFM) Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 600-603
Mann, B.; Müller-Berghaus, G. 1973: Intravasal precipitation of soluble fibrin by endotoxin Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1334-1335
Wardle, E.N. 1977: Fibrin monomer complexes in pre-eclampsia New England Journal of Medicine 296(1): 54
Celada, A.; Laso, F.J.; Perrin, L.H. 1979: Thrombotic thrombocytopenic purpura. An immune-complexes disease? Sangre 24(5): 593-599
Mahn, I.; von Drach, H.; Müller-Berghaus, G. 1976: In-vivo studies on the elimination of various soluble fibrin-preparations Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1643-1646
Eckhardt, T.; Müller-Berghaus, G. 1974: Significance of granulocytes in the intravascular precipitation of soluble fibrin through endotoxin Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1460-1463
Milanov, N.O.; Svetlov, V.A.; Babishcheva, A.V.; Zelianin, A.S.; Nikolaev, A.P.; Roĭtman, E.V. 2003: Prophylaxis of thrombotic complications in microsurgical auto-transplantation of tissue complexes Khirurgiia 2: 28-33
Pozdniakova, T.M.; Rybachuk, V.N. 1985: Complexes of the N-terminal disulfide branch point of fibrin with fibrinogen Ukrainskii Biokhimicheskii Zhurnal 57(1): 3-8
Coccheri, S.; Palareti, G. 1994: Pro-thrombotic states and their diagnosis Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 9(1): 16-21
Colle, J.P.; Mishal, Z.; Lesty, C.; Mirshahi, M.; Peyne, J.; Baumelou, A.; Bensman, A.; Soria, J.; Soria, C. 1999: Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thrombosis and Haemostasis 82(5): 1482-1489
Kovalevskaia, I.L.; Shcheglova, E.S.; Korneeva, S.A.; Iarovaia, L.M.; Gofman, I.L. 1979: Immunogenic complexes of the soluble surface antigens of Sh. sonnei Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 30-36
Ishmukhametova, D.N.; Mozhina, A.A. 1984: Relation of the formation of the fibrin network of a blood clot to the amount of thrombin in complexes with endogenous heparin Anesteziologiia i Reanimatologiia 2: 30-34
Ito, S.; Mikawa, H.; Shinomiya, K.; Yoshida, T. 1979: Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis Clinical and Experimental Immunology 37(3): 436-440
Ciobanu, V.; Zălaru, M. 1972: Role of soluble immune complexes in pathogenesis of some inflammatory processes Medicina Interna 24(7): 793-802
Koga, S. 2004: A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF) Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 355-361
Kidani, Y.; Noji, M.; Tsukagoshi, S.; Tashiro, T. 1978: Antitumor activity of water-soluble platinum(II) complexes of 1,2-cyclohexanediamine isomers Gan 69(2): 263-265
Motie, M.; Brockmeier, S.; Potempa, L.A. 1996: Binding of model soluble immune complexes to modified C-reactive protein Journal of Immunology 156(11): 4435-4441